Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
60%
Ph phase_4
1
20%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 33 (60.0%)
Phase 41 (20.0%)

Trials by Status

active_not_recruiting120%
completed360%
enrolling_by_invitation120%

Recent Activity

1 active trials
Showing 5 of 5
enrolling_by_invitationphase_4

An Immunity Persistence Study of Live Attenuated Varicella Vaccine

NCT05095701
active_not_recruitingphase_3

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine

NCT05669625
completedphase_3

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

NCT05150392
completedphase_1

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

NCT02965404
completedphase_3

A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines

NCT02981836

Clinical Trials (5)

Showing 5 of 5 trials
NCT05095701Phase 4

An Immunity Persistence Study of Live Attenuated Varicella Vaccine

Enrolling By Invitation
NCT05669625Phase 3

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine

Active Not Recruiting
NCT05150392Phase 3

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Completed
NCT02965404Phase 1

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

Completed
NCT02981836Phase 3

A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5